DENVER-National Jewish Center for Immunology and Respiratory Medicine will receive $2 million in annual funding for five years from the disease management unit of Schering Plough Corp. Their alliance will develop asthma programs, i ncluding treatment plans, patient education, disease management and wellness. Ownership of most results probably will be joint; however, in some cases the results will belong to the party that originated them, said Lynn Taussig, M. D., president and chief executive officer of National Jewish. Disease management involves developing tactics for coordinating patient care throughout the healthcare system and the course of a disease (June 12, 1995, p. 30).
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.